Target intelligence / Profile preview

Human papillomavirus type 6 L1 major capsid protein (HPV6 L1)

Target
HPV6 L1
Molecular classification
Structural viral protein, Capsid protein, Other
01

Overview

The Human papillomavirus type 6 L1 major capsid protein is the principal structural component forming the outer shell of the virus. It self assembles into pentameric units called capsomeres, which further organize into an icosahedral capsid with T=7 symmetry and approximately 50 nm diameter. The assembled structure encapsulates and protects the viral genome during transmission. The L1 protein has intrinsic DNA-binding activity and plays a role in stabilizing the viral genome during intracellular trafficking after cell entry. Recombinant forms of this protein are used to create virus-like particles that serve as antigens in prophylactic vaccines such as Gardasil, eliciting strong neutralizing antibody responses that confer protection against infection by human papillomavirus type 6 and related types[3][2][4].

Other names
HPV-6 L1Major capsid protein L1 (HPV6)HPV type 6 major capsid proteinL1 protein (HPV6)
02

Mechanism of action

Induction of neutralizing antibodies that prevent viral entry by targeting conformational epitopes on assembled L1 pentamers/capsomeres[2][4]

03

Biological functions

Formation of viral capsid structureDNA binding within the virion[1]Immune response induction (as a vaccine antigen)[2][4]
04

Disease associations

Infection (specifically, human papillomavirus infection)[3]Other (serves as an immunogen in prophylactic vaccines against HPV-related diseases)
05

Safety considerations

Minimal safety concerns when used as a recombinant vaccine antigen; not associated with oncogenicity or toxicity in this context[4]
06

Interacting drugs

Gardasil (quadrivalent and nonavalent HPV vaccines contain recombinant L1 proteins from multiple types, including type 6)[2][4]
07

Biomarkers

Presence of anti-L1 antibodies as a marker for vaccination or prior exposure to HPV[2]

Beyond the preview

Go deeper on Human papillomavirus type 6 L1 major capsid protein (HPV6 L1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human papillomavirus type 6 L1 major capsid protein (HPV6 L1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call